Fetal thyrotoxicosis: a case report and recommendations for prediction, diagnosis, and treatment.
A maternal history of Graves' disease places the fetus at risk for thyrotoxicosis in utero via the placental transfer of thyroid-stimulating immunoglobulins. Methods for prediction of fetal hyperthyroidism are available, but are not widely used. Clinical assessment of fetal thyroid status by monitoring of fetal heart rate and growth may be inaccurate. This raises some uncertainty in the initial diagnosis of fetal thyrotoxicosis and complicates the assessment of fetal response to maternal propylthiouracil therapy. A case illustrating these pitfalls in the diagnosis and management of fetal hyperthyroidism is presented. The condition was correctly diagnosed, but treatment based on fetal heart rate resulted in biochemical hypothyroidism in the infant at birth. Current recommendations for diagnosis and treatment of fetal hyperthyroidism are reviewed along with recent developments in the field. A modified approach is proposed.
Wallace
C
C
Department of Endocrinology, University of Alberta, Edmonton, Canada.
Couch
R
R
Ginsberg
J
J
D000328:Adult; D000465:Algorithms; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis* / Q000628:therapy*; D006111:Graves Disease / Q000150:complications; D006340:Heart Rate, Fetal / Q000502:physiology; D006801:Humans; D011247:Pregnancy; D011296:Prenatal Diagnosis; D011441:Propylthiouracil / Q000627:therapeutic use; D013971:Thyrotoxicosis / Q000175:diagnosis* / Q000188:drug therapy / Q000628:therapy*; D014284:Triiodothyronine / Q000097:blood
D014284:Triiodothyronine; D011441:Propylthiouracil